Identification of key transcription factors in preeclampsia

References

• Turpin CA, Sakyi SA, Owiredu WK, et al. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia. BMC Pregnancy Childbirth. 2015 Aug 25;15:189. PubMed PMID: 26303772; PubMed Central PMCID: PMC4549075.
   PubMed Web of Science ®Google Scholar
• Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003 Jul;102(1):181–192. PubMed PMID: 12850627
   PubMed Web of Science ®Google Scholar
• Suplee PD, Dawley K, Bloch JR. Tailoring peripartum nursing care for women of advanced maternal age. J Obstet Gynecologic Neonatal Nurs. 2007 Nov-Dec;36(6):616–623. . PubMed PMID: 17973707
   PubMed Web of Science ®Google Scholar
• Huang L, Sauve R, Birkett N, et al. Maternal age and risk of stillbirth: a systematic review. CMAJ = Journal De l’Association Medicale Canadienne. 2008 Jan 15;178(2):165–172. PubMed PMID: 18195290; PubMed Central PMCID: PMC2175002.
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003 Mar;111(5):649–658. PubMed PMID: 12618519; PubMed Central PMCID: PMC151901.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006 Sep 7;355(10):992–1005. PubMed PMID: 16957146.
   PubMed Web of Science ®Google Scholar
• Verlohren S, Herraiz I, Lapaire O, et al. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension. 2014 Feb;63(2):346–352. PubMed PMID: 24166751.
   PubMed Web of Science ®Google Scholar
• Jebbink JM, Boot RG, Keijser R, et al. Increased glucocerebrosidase expression and activity in preeclamptic placenta. Placenta. 2015 Feb;36(2):160–169. PubMed PMID: 25552189.
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B. 1995 Nov;1(57):289–300. PubMed PMID: 11682119
   Google Scholar
• Wu S, Wu H. More powerful significant testing for time course gene expression data using functional principal component analysis approaches. BMC Bioinformatics. 2013 Jan 16;14:6. . PubMed PMID: 23323795; PubMed Central PMCID: PMC3617096.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Topham DJ, Thakar J, et al. FUNNEL-GSEA: FUNctioNal ELastic-net regression in time-course gene set enrichment analysis. Bioinformatics. 2017 Jul 1;33(13):1944–1952. PubMed PMID: 28334094.
   PubMed Web of Science ®Google Scholar
• Zheng G, Tu K, Yang Q, et al. ITFP: an integrated platform of mammalian transcription factors. Bioinformatics. 2008 Oct 15;24(20):2416–2417. PubMed PMID: 18713790.
   PubMed Web of Science ®Google Scholar
• Marbach D, Lamparter D, Quon G, et al. Tissue-specific regulatory circuits reveal variable modular perturbations across complex diseases. Nat Methods. 2016 Apr;13(4):366–370. PubMed PMID: 26950747; PubMed Central PMCID: PMC4967716.
   PubMed Web of Science ®Google Scholar
• Han H, Shim H, Shin D, et al. TRRUST: a reference database of human transcriptional regulatory interactions. Sci Rep. 2015 Jun;12(5):11432. PubMed PMID: 26066708; PubMed Central PMCID: PMC4464350.
   PubMed Web of Science ®Google Scholar
• Sitras V, Paulssen RH, Gronaas H, et al. Differential placental gene expression in severe preeclampsia. Placenta. 2009 May;30(5):424–433. PubMed PMID: 19249095.
   PubMed Web of Science ®Google Scholar
• Meng T, Chen H, Sun M, et al. Identification of differential gene expression profiles in placentas from preeclamptic pregnancies versus normal pregnancies by DNA microarrays. OMICS. 2012 Jun;16(6):301–311. PubMed PMID: 22702245; PubMed Central PMCID: PMC3369279.
   PubMed Web of Science ®Google Scholar
• Nishizawa H, Pryor-Koishi K, Kato T, et al. Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Placenta. 2007 May-Jun;28(5–6):487–497. PubMed PMID: 16860862.
   PubMed Web of Science ®Google Scholar
• Sitras V, Fenton C, Acharya G. Gene expression profile in cardiovascular disease and preeclampsia: a meta-analysis of the transcriptome based on raw data from human studies deposited in Gene Expression Omnibus. Placenta. 2015 Feb;36(2):170–178. . PubMed PMID: 25555499
   PubMed Web of Science ®Google Scholar
• Rajakumar A, Brandon HM, Daftary A, et al. Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae. Placenta. 2004 Nov;25(10):763–769. PubMed PMID: 15451190.
   PubMed Web of Science ®Google Scholar
• Rajakumar A, Whitelock KA, Weissfeld LA, et al. Selective overexpression of the hypoxia-inducible transcription factor, HIF-2alpha, in placentas from women with preeclampsia. Biol Reprod. 2001 Feb;64(2):499–506. PubMed PMID: 11159352
   PubMed Web of Science ®Google Scholar
• Chou J, Lin JH, Brenot A, et al. GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression. Nat Cell Biol. 2013 Feb;15(2):201–213. PubMed PMID: 23354167; PubMed Central PMCID: PMC3660859.
   PubMed Web of Science ®Google Scholar
• Karumanchi SA. Angiogenic factors in preeclampsia: from diagnosis to therapy. Hypertension. 2016 Jun;67(6):1072–1079. . PubMed PMID: 27067718.
   PubMed Web of Science ®Google Scholar
• Zhang K, Cai HX, Gao S, et al. TNFSF15 suppresses VEGF production in endothelial cells by stimulating miR-29b expression via activation of JNK-GATA3 signals. Oncotarget. 2016 Oct 25;7(43):69436–69449. PubMed PMID: 27589684; PubMed Central PMCID: PMC5342489.
   PubMedGoogle Scholar
• Deepak V, Sahu MB, Yu J, et al. Retinoic acid is a negative regulator of sFLT1 expression in decidual stromal cells, and its levels are reduced in preeclamptic decidua. Hypertension. 2019 May;73(5):1104–1111. PubMed PMID: 30879360.
   PubMed Web of Science ®Google Scholar
• Mirza A, McGuirk M, Hockenberry TN, et al. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene. 2002 Apr 18;21(17):2613–2622. PubMed PMID: 11965534.
   PubMed Web of Science ®Google Scholar
• Miyashita T, Krajewski S, Krajewska M, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994 Jun;9(6):1799–1805. PubMed PMID: 8183579
   PubMed Web of Science ®Google Scholar
• Gao Q, Zhu X, Chen J, et al. Upregulation of P53 promoted G1 arrest and apoptosis in human umbilical cord vein endothelial cells from preeclampsia. J Hypertens. 2016 Jul;34(7):1380–1388. PubMed PMID: 27115339; PubMed Central PMCID: PMC5649442.
   PubMed Web of Science ®Google Scholar
• Sargent IL, Germain SJ, Sacks GP, et al. Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. J Reprod Immunol. 2003 Aug;59(2):153–160. PubMed PMID: 12896819
   PubMed Web of Science ®Google Scholar